联环药业：获得他达拉非片药品补充申请批准通知书

Core Viewpoint - The company, Lianhuan Pharmaceutical, has received approval from the National Medical Products Administration for the supplemental application of Tadalafil tablets, allowing for the introduction of new specifications [1] Group 1: Product Approval - The approval includes the addition of 2.5mg and 5mg specifications for Tadalafil tablets [1] - Tadalafil is primarily used for the treatment of erectile dysfunction in both 2.5mg and 5mg specifications, and for the treatment of erectile dysfunction combined with benign prostatic hyperplasia only in the 5mg specification [1]